Olema to Present Palazestrant and OP-3136 Combination Data at Breast Cancer Symposium
Olema Pharmaceuticals says it will present combination data from its palazestrant and OP-3136 programs at the 2026 San Antonio Breast Cancer Symposium.
Olema Pharmaceuticals says it will present combination data from its palazestrant and OP-3136 programs at the 2026 San Antonio Breast Cancer Symposium.